A Study of GensSci098 in Subjects With Graves' Disease

Clinical trial NCT07286656 · RECRUITING

Trial details

NCT number: NCT07286656
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Tolerability GenSci098 Graves Disease

Start date: 2025-11-21
Primary completion: 2026-10-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.